Skip to main content
Clinical Trials/NCT06096493
NCT06096493
Recruiting
Not Applicable

Predictors of Disease Free Survival After Curative Cancer Rectum Surgery

South Valley University1 site in 1 country200 target enrollmentStarted: May 1, 2023Last updated:
ConditionsRectal Cancer

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
200
Locations
1
Primary Endpoint
Tumor recurrence

Overview

Brief Summary

Tumor recurrence after curative surgical resection for rectal cancer is a serious complication that greatly affects the overall morbidity and the outcome. This study aims to identify the different prognostic factors affecting recurrence and disease-free survival after surgery.

Detailed Description

A retrospective analysis of patients operated for cancer rectum with curative intent from.

Exclusion criteria will include patients with familial adenomatous polyposis, multiple synchronous or metachronous rectal cancers, and death within 3 months. Incomplete patients' files and patients that lost follow-up will be excluded.

Demographic, histopathological, follow up and outcome data will be collected from completed patients' files. Demographics include age, gender, family history, and chief complaint at the presentation. Histopathological data include tumor grade, vascular-perineural invasion, the total number of lymph nodes removed, and positive lymph nodes.

Lymph node ratio will be defined as the ratio of positive lymph nodes to the total number of retrieved lymph nodes in a histopathology specimen. Disease-free survival will be calculated for each patient based on the time of surgery to the time of recurrence detection.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients who had curative surgery for cancer rectum.

Exclusion Criteria

  • Patients with familial adenomatous polyposis (FAP), multiple synchronous or metachronous rectal cancers, and death within 3 months
  • Patients that lost follow-up will be excluded.

Outcomes

Primary Outcomes

Tumor recurrence

Time Frame: Through study completion, an average of 3 year

Presence of Tumor recurrence after curative surgery for cancer rectum.

Disease free survival.

Time Frame: up to 5 years

From date of surgery until the date of recurrence detection.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Abdallah Mohamed Taha Aly

Assistant Professor of general Surgery

South Valley University

Study Sites (1)

Loading locations...

Similar Trials